BrightSpring Health Services, Inc. (BTSG)
NASDAQ:BTSG
Want to see BTSG full AI Analyst Report?
BTSG Stock Chart & Stats
$47.27
-$0.12(-0.69%)
At close: 4:00 PM EST
$47.27
-$0.12(-0.69%)
Day’s Range― - ―
52-Week Range$16.34 - $48.97
Previous CloseN/A
Volume351.53K
Average Volume (3M)2.43M
Market Cap
$9.30B
Enterprise Value$11.93B
Total Cash (Recent Filing)$88.37M
Total Debt (Recent Filing)$2.84B
Price to Earnings (P/E)39.8
Beta1.01
Next Earnings
May 01, 2026EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.33
Shares Outstanding193,167,720
10 Day Avg. Volume1,656,197
30 Day Avg. Volume2,425,735
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)4.05
Price to Sales (P/S)0.59
P/FCF Ratio19.22
Enterprise Value/Market Cap1.28
Enterprise Value/Revenue0.92
Enterprise Value/Gross Profit7.86
Enterprise Value/Ebitda25.96
Forecast
1Y Price Target
$52.16Price Target Upside10.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)1.56
Revenue Forecast (FY)$14.85B
Bulls Say, Bears Say
Bulls Say
Growth TargetsManagement's ambitious organic EBITDA growth framework signals continued margin expansion and potential for valuation multiple improvement as profitability trends strengthen.
Pharmacy Market DynamicsBroader adoption of generics and biosimilars combined with structurally narrower limited-distribution networks favors established specialty pharmacies and can lift revenue and margins from new drug launches.
Specialty And Infusion ExpansionInvestments in rare and orphan drug services and expanded infusion capabilities position the company to capture higher-margin specialty volumes beyond core oncology.
Bears Say
Acquisition-related EBITDA DragRecently acquired home health assets are expected to dampen near-term EBITDA due to integration costs and lower initial margins affecting consolidated profitability.
Drug Pricing And Genericization RiskChanges in drug pricing rules and shifts from branded to generic products create a notable revenue headwind for Pharmacy Solutions and Home and Community businesses.
Prescription Volume PressureA slight decline in total prescriptions dispensed indicates potential volume weakness that could constrain top-line growth even if revenue per script rises.
BrightSpring Health Services, Inc. News
BTSG FAQ
What was BrightSpring Health Services, Inc.’s price range in the past 12 months?
BrightSpring Health Services, Inc. lowest stock price was $16.34 and its highest was $48.97 in the past 12 months.
What is BrightSpring Health Services, Inc.’s market cap?
BrightSpring Health Services, Inc.’s market cap is $9.30B.
When is BrightSpring Health Services, Inc.’s upcoming earnings report date?
BrightSpring Health Services, Inc.’s upcoming earnings report date is May 01, 2026 which is in 2 days.
How were BrightSpring Health Services, Inc.’s earnings last quarter?
BrightSpring Health Services, Inc. released its earnings results on Feb 27, 2026. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.346 by -$0.016.
Is BrightSpring Health Services, Inc. overvalued?
According to Wall Street analysts BrightSpring Health Services, Inc.’s price is currently Undervalued.
Does BrightSpring Health Services, Inc. pay dividends?
BrightSpring Health Services, Inc. does not currently pay dividends.
What is BrightSpring Health Services, Inc.’s EPS estimate?
BrightSpring Health Services, Inc.’s EPS estimate is 0.31.
How many shares outstanding does BrightSpring Health Services, Inc. have?
BrightSpring Health Services, Inc. has 193,167,720 shares outstanding.
What happened to BrightSpring Health Services, Inc.’s price movement after its last earnings report?
BrightSpring Health Services, Inc. reported an EPS of $0.33 in its last earnings report, missing expectations of $0.346. Following the earnings report the stock price went up 3.239%.
Which hedge fund is a major shareholder of BrightSpring Health Services, Inc.?
Currently, no hedge funds are holding shares in BTSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BrightSpring Health Services, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$52.16 (10.35% Upside)
$52.16 (10.35% Upside)
Blogger Sentiment
Bullish
BTSG Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 71.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.6B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 9.2%
Last 30 Days ▲ 9.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
184.75%
12-Months-Change
Fundamentals
Return on Equity
10.71%
Trailing 12-Months
Asset Growth
3.47%
Trailing 12-Months
Company Description
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
BTSG Company Deck
BTSG Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was predominantly positive: BrightSpring reported strong 2025 results with robust revenue (28% YoY) and EBITDA (34% YoY) growth, meaningful improvement in cash flow and leverage, high-quality operational metrics across business lines, and confident 2026 guidance (midpoint implying ~14% revenue and ~25% EBITDA growth). Management also outlined strategic M&A activity (Amedisys acquisition) and a pending Community Living divestiture expected to generate ~$715M of net proceeds to further reduce leverage. Offsetting these positives are notable near-term headwinds from IRA and brand-to-generic conversions (gross impacts quantified in the hundreds of millions), disruption from a large customer bankruptcy and exit of uneconomic customers, and integration/timing risk related to acquired assets. Overall, the highlights—strong growth, cash generation, margin expansion, and balance sheet improvement—outweigh the lowlights, which are being actively managed.View all BTSG earnings summariesBTSG Stock 12 Month Forecast
Average Price Target
$52.16
▲(10.35% Upside)
Technical Analysis
Ownership Overview
44.50% Insiders
29.83% Mutual Funds
0.56% Other Institutional Investors
5.65% Public Companies and
Individual Investors